↓ Skip to main content

Non-Exosomal and Exosomal Circulatory MicroRNAs: Which Are More Valid as Biomarkers?

Overview of attention for article published in Frontiers in Pharmacology, January 2020
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
151 Dimensions

Readers on

mendeley
204 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Non-Exosomal and Exosomal Circulatory MicroRNAs: Which Are More Valid as Biomarkers?
Published in
Frontiers in Pharmacology, January 2020
DOI 10.3389/fphar.2019.01500
Pubmed ID
Authors

Nik Nur Syazana Binti Nik Mohamed Kamal, Wan Nazatul Shima Shahidan

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 204 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 204 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 31 15%
Student > Master 24 12%
Student > Ph. D. Student 22 11%
Student > Bachelor 22 11%
Student > Doctoral Student 10 5%
Other 28 14%
Unknown 67 33%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 54 26%
Medicine and Dentistry 18 9%
Agricultural and Biological Sciences 12 6%
Pharmacology, Toxicology and Pharmaceutical Science 8 4%
Veterinary Science and Veterinary Medicine 6 3%
Other 27 13%
Unknown 79 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 April 2020.
All research outputs
#15,837,686
of 26,371,446 outputs
Outputs from Frontiers in Pharmacology
#5,325
of 20,320 outputs
Outputs of similar age
#256,780
of 485,884 outputs
Outputs of similar age from Frontiers in Pharmacology
#157
of 431 outputs
Altmetric has tracked 26,371,446 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 20,320 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 485,884 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 431 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.